{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:49Z","timestamp":1790813989407,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2123683"],"award-info":[{"award-number":["2123683"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Optimizing immunosuppressive therapy remains central to improving long-term outcomes after kidney transplantation. Both induction and maintenance therapies are widely used, yet their comparative effectiveness across diverse recipient populations requires further evaluation. This national retrospective cohort study analyzed 228,855 deceased-donor kidney transplant recipients using data from 2000\u20132024. Multivariable Cox proportional hazards (PH) models were used for clinical inference, and four machine learning (ML) survival models: random survival forest (RSF), support vector machine (SVM), penalized Cox regression (CoxNet), and extreme gradient boosting optimized with the Cox partial likelihood (XGBoost-Cox), were developed to assess predictive performance for death-censored graft failure and all-cause patient mortality. Model performance was evaluated using the concordance index (C-index) and time-dependent area under the curve (tdAUC). Maintenance regimens incorporating calcineurin inhibitors (CNI) and mycophenolate mofetil (MMF) were associated with lower hazards for both graft failure (CNI\u2009+\u2009MMF: hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.70\u20130.74; CNI\u2009+\u2009MMF+steroids: HR 0.84, 95% CI 0.82\u20130.87) and patient mortality (CNI\u2009+\u2009MMF: HR 0.78, 95% CI 0.76\u20130.81; CNI\u2009+\u2009MMF+steroids: HR 0.90, 95% CI 0.88\u20130.93). Among induction therapies, antithymocyte globulin (ATG) was associated with lower hazards for both outcomes, whereas interleukin-2 receptor (IL-2R) antagonists and Alemtuzumab demonstrated neutral associations. Combined ATG\u2009+\u2009IL-2R therapy was associated with higher hazard of graft failure (HR 1.09). Recipient diabetes, dialysis dependence, older age, and higher Kidney Donor Profile Index were strong adverse predictors. Traditional Cox regression achieved robust discrimination (graft failure C-index: 0.685; patient mortality C-index: 0.704), comparable to ML survival models. These findings support the continued association of CNI and MMF maintenance regimens with favorable long-term transplant outcomes while demonstrating variation across induction strategies. The dual analytical framework integrating classical Cox modeling with ML survival methods, suggests that Cox models remain highly competitive for clinical inference, whereas ML approaches provide complementary predictive value to support individualized post-transplant risk stratification.<\/jats:p>","DOI":"10.1371\/journal.pone.0339109","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:47:23Z","timestamp":1782496043000},"page":"e0339109","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunosuppressive regimens and long-term kidney transplant outcomes: A dual survival modeling framework"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0199-7111","authenticated-orcid":true,"given":"Kunle","family":"Apanisile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"El-Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-0898","authenticated-orcid":true,"given":"Naoru","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"2","key":"pone.0339109.ref001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"M Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"pone.0339109.ref002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncpneph0383","article-title":"Living donor renal transplantation: recent developments and perspectives","volume":"3","author":"S Baid-Agrawal","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"26","key":"pone.0339109.ref003","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive Drugs for Kidney Transplantation","volume":"351","author":"PF Halloran","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0339109.ref004","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-Mediated Rejection of Solid-Organ Allografts","volume":"379","author":"A Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0339109.ref005","doi-asserted-by":"crossref","first-page":"682334","DOI":"10.3389\/fimmu.2021.682334","article-title":"Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells","volume":"12","author":"Y Matsuda","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0339109.ref006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation","volume":"25","author":"E Ingulli","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"9158","key":"pone.0339109.ref007","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"MD Denton","year":"1999","journal-title":"The Lancet"},{"issue":"3","key":"pone.0339109.ref008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2146\/ajhp090636","article-title":"Induction immunosuppressive therapies in renal transplantation","volume":"68","author":"S Gabardi","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"pone.0339109.ref009","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nri1204","article-title":"Individuality: the barrier to optimal immunosuppression","volume":"3","author":"BD Kahan","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"pone.0339109.ref010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12254-019-0507-4","article-title":"Immunosuppression after renal transplantation","volume":"12","author":"H Neuwirt","year":"2019","journal-title":"memo"},{"issue":"1","key":"pone.0339109.ref011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"R Hellemans","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"pone.0339109.ref012","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"BL Kasiske","year":"2010","journal-title":"Kidney Int"},{"issue":"7","key":"pone.0339109.ref013","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00007890-200204150-00015","article-title":"Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients","volume":"73","author":"G Ciancio","year":"2002","journal-title":"Transplantation"},{"issue":"9","key":"pone.0339109.ref014","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"S Hariharan","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0339109.ref015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"JD Pirsch","year":"1997","journal-title":"Transplantation"},{"issue":"2","key":"pone.0339109.ref016","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year","volume":"77","author":"G Ciancio","year":"2004","journal-title":"Transplantation"},{"issue":"7","key":"pone.0339109.ref017","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/TP.0b013e31819cdddd","article-title":"Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity","volume":"87","author":"K Heldal","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"pone.0339109.ref018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes Mellitus after Kidney Transplantation in the United States","volume":"3","author":"BL Kasiske","year":"2003","journal-title":"Am J Transplant"},{"issue":"7","key":"pone.0339109.ref019","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1503\/cmaj.091661","article-title":"Predicting potential survival benefit of renal transplantation in patients with chronic kidney disease","volume":"182","author":"C Van Walraven","year":"2010","journal-title":"Can Med Assoc J"},{"key":"pone.0339109.ref020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"E Christodoulou","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"pone.0339109.ref021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41512-022-00126-w","article-title":"Risk of bias of prognostic models developed using machine learning: a systematic review in oncology","volume":"6","author":"P Dhiman","year":"2022","journal-title":"Diagn Progn Res"},{"key":"pone.0339109.ref022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2288-14-137","article-title":"Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints","volume":"14","author":"T van der Ploeg","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"pone.0339109.ref023","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000345552","article-title":"Bayesian modeling of pretransplant variables accurately predicts kidney graft survival","volume":"36","author":"TS Brown","year":"2012","journal-title":"Am J Nephrol"},{"issue":"1","key":"pone.0339109.ref024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12911-015-0206-y","article-title":"Prediction of delayed graft function after kidney transplantation: comparison between logistic regression and machine learning methods","volume":"15","author":"A Decruyenaere","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"pone.0339109.ref025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dss.2017.12.004","article-title":"Predicting graft survival among kidney transplant recipients: A Bayesian decision support model","volume":"106","author":"K Topuz","year":"2018","journal-title":"Decis Support Syst"},{"issue":"1","key":"pone.0339109.ref026","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1038\/s41598-017-08008-8","article-title":"A machine learning approach using survival statistics to predict graft survival in kidney transplant recipients: A multicenter cohort study","volume":"7","author":"KD Yoo","year":"2017","journal-title":"Scientific Reports"},{"issue":"25","key":"pone.0339109.ref027","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0339109.ref028","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review","volume":"87","author":"SR Knight","year":"2009","journal-title":"Transplantation"},{"key":"pone.0339109.ref029","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000187035.22298.ba","article-title":"Review of major clinical trials with mycophenolate mofetil in renal transplantation","volume":"80","author":"G Ciancio","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"pone.0339109.ref030","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0041-1345(02)03032-4","article-title":"Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study","volume":"34","author":"J-P Squifflet","year":"2002","journal-title":"Transplant Proc"},{"issue":"9","key":"pone.0339109.ref031","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection","volume":"70","author":"Y Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"key":"pone.0339109.ref032","first-page":"9","article-title":"Rabbit anti-thymocyte globulin induction in renal transplantation: review of the literature","volume":"6","author":"L Andress","year":"2014","journal-title":"Transpl Res Risk Manag"},{"issue":"24","key":"pone.0339109.ref033","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: A review of its use as induction therapy in renal transplantation","volume":"63","author":"TM Chapman","year":"2003","journal-title":"Drugs"},{"issue":"7","key":"pone.0339109.ref034","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/phar.1774","article-title":"Single-Dose Basiliximab Induction in Low-Risk Renal Transplant Recipients","volume":"36","author":"KC Cunningham","year":"2016","journal-title":"Pharmacotherapy"},{"key":"pone.0339109.ref035","doi-asserted-by":"crossref","first-page":"1253991","DOI":"10.3389\/fimmu.2023.1253991","article-title":"Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study","volume":"14","author":"TF Heldal","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0339109.ref036","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000320749","article-title":"Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure","volume":"32","author":"KJ Kelly","year":"2010","journal-title":"Am J Nephrol"},{"key":"pone.0339109.ref037","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3389\/fimmu.2020.00954","article-title":"Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes","volume":"11","author":"M Gerbase-DeLima","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0339109.ref038","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/ndt\/gfr524","article-title":"Age is an important predictor of kidney transplantation outcome","volume":"27","author":"M Veroux","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0339109.ref039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000358497","article-title":"Impact of Age, Race and Ethnicity on Dialysis Patient Survival and Kidney Transplantation Disparities","volume":"39","author":"CM Rhee","year":"2014","journal-title":"Am J Nephrol"},{"issue":"1","key":"pone.0339109.ref040","doi-asserted-by":"crossref","first-page":"11234","DOI":"10.1038\/s41598-019-47772-7","article-title":"Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor\u2019s kidneys\u2019 outcome in a European cohort","volume":"9","author":"M Dahmen","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0339109.ref041","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/TP.0000000000002498","article-title":"Reevaluation of the Kidney Donor Risk Index","volume":"103","author":"Y Zhong","year":"2019","journal-title":"Transplantation"},{"key":"pone.0339109.ref042","doi-asserted-by":"crossref","first-page":"875206","DOI":"10.3389\/fmed.2022.875206","article-title":"The Kidney Donor Profile Index (KDPI) Correlates With Histopathologic Findings in Post-reperfusion Baseline Biopsies and Predicts Kidney Transplant Outcome","volume":"9","author":"Q Bachmann","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"pone.0339109.ref043","doi-asserted-by":"crossref","first-page":"2391067","DOI":"10.1080\/0886022X.2024.2391067","article-title":"The impact of donor diabetes on recipient postoperative complications, renal function, and survival rate in deceased donor kidney transplantation: a single-center analysis","volume":"46","author":"Q Chen","year":"2024","journal-title":"Ren Fail"},{"issue":"1","key":"pone.0339109.ref044","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41379-021-00927-2","article-title":"Long-standing donor diabetes and pathologic findings are associated with shorter allograft survival in recipients of kidney transplants from diabetic donors","volume":"35","author":"A Gilbert","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"pone.0339109.ref045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ki.2014.304","article-title":"Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation","volume":"87","author":"A Debout","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0339109.ref046","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000888","article-title":"Impact of cold ischemia time on outcomes of deceased donor kidney transplantation: an analysis of a national registry","volume":"5","author":"H Peters-Sengers","year":"2019","journal-title":"Transplant Direct"},{"issue":"1","key":"pone.0339109.ref047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209068","volume":"14","author":"E Mark","year":"2019","journal-title":"PLOS ONE"},{"issue":"11","key":"pone.0339109.ref048","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/tri.13695","article-title":"Machine learning to predict transplant outcomes: helpful or hype? A national cohort study","volume":"33","author":"S Bae","year":"2020","journal-title":"Transpl Int"},{"issue":"6","key":"pone.0339109.ref049","article-title":"Machine Learning Support for Decision-Making in Kidney Transplantation: Step-by-step Development of a Technological Solution","volume":"10","author":"F-X Paquette","year":"2022","journal-title":"JMIR Med Inform"},{"key":"pone.0339109.ref050","author":"M Luck","year":"2017"},{"issue":"1","key":"pone.0339109.ref051","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12874-021-01319-5","article-title":"Development and validation of a risk index to predict kidney graft survival: the kidney transplant risk index","volume":"21","author":"S Senanayake","year":"2021","journal-title":"BMC Med Res Methodol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:47:33Z","timestamp":1782496053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339109"}},"subtitle":[],"editor":[{"given":"Rajendra","family":"Bhimma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339109","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}